Seroprevalence of Campylobacter Jejuni in Patients with Irritable Bowel Syndrome and in Healthy Individuals

Gharavi, MJ; Roozbehani, M; Ajodani, AH; Yosefi Darestani, S

Volume 7, Issue 4 (winter[PERSIAN] 2014) mljgoums 2014, 7(4): 72-77 | Back to browse issues page

Mendeley

Zotero

RefWorks

Gharavi M, Roozbehani M, Ajodani A, Yosefi Darestani S. Seroprevalence of Campylobacter Jejuni in Patients with Irritable Bowel Syndrome and in Healthy Individuals. mljgoums 2014; 7 (4) :72-77
URL: http://mlj.goums.ac.ir/article-1-346-en.html

Seroprevalence of Campylobacter Jejuni in Patients with Irritable Bowel Syndrome and in Healthy Individuals

MJ Gharavi¹

, M Roozbehani

², AH Ajodani³

, S Yosefi Darestani⁴

1- Professor of Medical Parasitology, School of Paramedicine, Iran University of Medical Sciences
2- MSc of Medical Parasitology, School of Health, Iran University of Medical Sciences , mona.roozbehani@yahoo.com
3- BSc of Medical Laboratory, School of Paramedicine, Iran University of Medical Sciences,
4- BSc of Medical Laboratory, School of Paramedicine, Iran University of Medical Sciences

Abstract: (13913 Views)

Abstract Background and Objective: The patients with Post-Infectious Irritable bowel syndrome (PI-IBS), a subtype of irritable bowel syndrome, suffer from bacterial gastroenteritis. Since campylobacter Jejuni (CJ) is one of the most common agents in this syndrome, we aimed to evaluate the prevalence of Campylobacter Jejuni in patients with Irritable Bowel Disease. Material and Methods: This case - control study was conducted on 160 patients divided into 2 equal groups of healthy and unhealthy. The presence of Anti- CJ antibody (IgG and IgA) was evaluated by ELISA and the comparison was performed by chi-square test. Results: The mean age of case (31.51) and control (31.84) was not statistically different (P = 0.87). Titer of Anti- Campylobacter Jejuni antibody IgG was positive in 25% of patients and 18.8% of the healthy ones (p=0.02). IgA Seropositivity in patients was 7.5% but no one in control group was positive (p =0.01) Conclusion: Seroprevalence of Cj in patients with IBS was higher significantly than that of control group. Thus, Cj can be known as one of the causes of Post-infection in patients with IBS in our region and it should be paid more attention in diagnostic assessment of these patients. Keyword: Irritable Bowel Syndrome Campylobacter Jejuni Antibody

Keywords: Irritable Bowel Syndrome, Campylobacter Jejuni, Antibody

Full-Text [PDF 644 kb] | Full Text (HTML) [English Abstract] (2577 Downloads)

Research Article: Original Paper |
Received: 2013/09/11 | Accepted: 2013/10/13 | Published: 2013/10/13 | ePublished: 2013/10/13